A catalog of associations between rare coding variants and COVID-19 outcomes

Genome-wide Association Study Exome Coronavirus
DOI: 10.1101/2020.10.28.20221804 Publication Date: 2020-11-03T22:15:39Z
ABSTRACT
ABSTRACT Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes coronavirus disease-19 (COVID-19), a illness that can result in hospitalization or death. We investigated associations between rare genetic variants and seven COVID-19 outcomes 543,213 individuals, including 8,248 with COVID-19. After accounting for multiple testing, we did not identify any clear either exome-wide when specifically focusing on (i) 14 interferon pathway genes which deleterious have been reported severe patients; (ii) 167 located GWAS risk loci; (iii) 32 additional of immunologic relevance and/or therapeutic potential. Our analyses indicate there are no significant protein-coding detectable effect sizes at our current sample sizes. Analyses will be updated as data become available, results publicly browsable https://rgc-covid19.regeneron.com .
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (50)
CITATIONS (20)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....